Detalhe da pesquisa
1.
Study of chromatin remodeling genes implicates SMARCA4 as a putative player in oncogenesis in neuroblastoma.
Int J Cancer
; 145(10): 2781-2791, 2019 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31018240
2.
HMCan-diff: a method to detect changes in histone modifications in cells with different genetic characteristics.
Nucleic Acids Res
; 45(8): e58, 2017 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28053124
3.
Reversible transitions between noradrenergic and mesenchymal tumor identities define cell plasticity in neuroblastoma.
Nat Commun
; 14(1): 2575, 2023 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37142597
4.
The CDKN2A/CDKN2B/CDK4/CCND1 pathway is pivotal in well-differentiated and dedifferentiated liposarcoma oncogenesis: an analysis of 104 tumors.
Genes Chromosomes Cancer
; 50(11): 896-907, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21910158
5.
BET and CDK Inhibition Reveal Differences in the Proliferation Control of Sympathetic Ganglion Neuroblasts and Adrenal Chromaffin Cells.
Cancers (Basel)
; 14(11)2022 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35681734
6.
Single-cell transcriptomics reveals shared immunosuppressive landscapes of mouse and human neuroblastoma.
J Immunother Cancer
; 10(8)2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36054452
7.
MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone.
Mod Pathol
; 24(5): 624-37, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21336260
8.
ALK mutation dynamics and clonal evolution in a neuroblastoma model exhibiting two ALK mutations.
Oncotarget
; 10(48): 4937-4950, 2019 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31452835
9.
Activated ALK signals through the ERK-ETV5-RET pathway to drive neuroblastoma oncogenesis.
Oncogene
; 37(11): 1417-1429, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29321660
10.
Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries.
Nat Genet
; 49(9): 1408-1413, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28740262
11.
High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma.
EBioMedicine
; 53: 102702, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32200273
12.
Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma.
Oncotarget
; 5(9): 2688-702, 2014 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24811913
13.
Characterization of rearrangements involving the ALK gene reveals a novel truncated form associated with tumor aggressiveness in neuroblastoma.
Cancer Res
; 73(1): 195-204, 2013 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23139213
14.
Breakpoint features of genomic rearrangements in neuroblastoma with unbalanced translocations and chromothripsis.
PLoS One
; 8(8): e72182, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23991058